Skip to main content
British Medical Journal logoLink to British Medical Journal
letter
. 1977 Feb 26;1(6060):573.

Adjuvant therapy of lung cancer.

PMCID: PMC1605201  PMID: 843810

Full text

PDF

Page 573

573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Price M. R. Tumor antigens and tumor-host relationships. Annu Rev Med. 1976;27:151–163. doi: 10.1146/annurev.me.27.020176.001055. [DOI] [PubMed] [Google Scholar]
  2. Bell C. E., Jr, Seetharam S. A plasma membrane antigen highly associated with oat-cell carcinoma of the lung and undetectable in normal adult tissue. Int J Cancer. 1976 Nov 15;18(5):605–611. doi: 10.1002/ijc.2910180509. [DOI] [PubMed] [Google Scholar]
  3. Davies D. A., Buckham S., Manstone A. J. Protection of mice against syngeneic lymphomata: II. Collaboration between drugs and antibodies. Br J Cancer. 1974 Oct;30(4):305–311. doi: 10.1038/bjc.1974.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies D. A., Manstone A. J., Buckham S. Protection of mice against syngeneic lymphomata: I. Use of antibodies. Br J Cancer. 1974 Oct;30(4):297–304. doi: 10.1038/bjc.1974.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frost M. J., Rogers G. T., Bagshawe K. D. Extraction and preliminary characterization of a human bronchogenic carcinoma antigen. Br J Cancer. 1975 Apr;31(4):379–386. doi: 10.1038/bjc.1975.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hollinshead A. C., Stewart T. H., Herberman R. B. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. J Natl Cancer Inst. 1974 Feb;52(2):327–338. doi: 10.1093/jnci/52.2.327. [DOI] [PubMed] [Google Scholar]
  7. Roth J. A., Holmes E. C., Boddie A. W., Jr, Morton D. L. Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation. J Thorac Cardiovasc Surg. 1975 Oct;70(4):613–618. [PubMed] [Google Scholar]
  8. Schlager S. I., Paque R. E., Dray S. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts. Cancer Res. 1975 Aug;35(8):1907–1914. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES